JPMorgan Chase & Co’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $4.72M | Sell |
|
|||||
|
2022
Q4 | $7.13M | Buy |
|
|||||
|
2022
Q3 | $6.63M | Sell |
|
|||||
|
2022
Q2 | $7M | Buy |
|
|||||
|
2022
Q1 | $18K | Sell |
|
|||||
|
2021
Q4 | $21K | Buy |
|
|||||
|
2021
Q3 | $21K | Sell |
|
|||||
|
2021
Q2 | $24K | Buy |
|
|||||
|
2021
Q1 | $22K | Sell |
|
|||||
|
2020
Q4 | $27K | Sell |
|
|||||
|
2020
Q3 | $9K | Sell |
|
|||||
|
2020
Q2 | $10K | Buy |
|
|||||
|
2020
Q1 | $8K | Sell |
|
|||||
|
2019
Q4 | $255K | Sell |
|
|||||
|
2019
Q3 | $243K | Sell |
|
|||||
|
2019
Q2 | $318K | Sell |
|
|||||
|
2019
Q1 | $392K | Sell |
|
|||||
|
2018
Q4 | $310K | Sell |
|
|||||
|
2018
Q3 | $1.23M | Buy |
|
|||||
|
2018
Q2 | $1.69M | Buy |
|
|||||
|
2018
Q1 | $1.04M | Buy |
|
|||||
|
2017
Q4 | $290K | Buy |
|
|||||
|
2017
Q3 | $272K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $32K | Buy |
|
|||||
|
2016
Q4 | $3K | Buy |
|
|||||
|
2016
Q3 | $2K | Sell |
|
|||||
|
2016
Q2 | $4K | Sell |
|
|||||
|
2016
Q1 | $30K | Sell |
|
|||||
|
2015
Q4 | $121K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $44K | Buy |
|
|||||
|
2014
Q2 | $34K | Buy |
|
|||||
|
2014
Q1 | $35K | Hold |
|
|||||
|
2013
Q4 | $20K | Sell |
|
|||||
|
2013
Q3 | $25K | Sell |
|
|||||
|
2013
Q2 | $106K | Buy |
|